DaVita Inc. (DVA) is a prominent player in the kidney dialysis services industry in the United States, with a market cap of $7.3 billion. The company operates a network of outpatient dialysis centers and clinical laboratories, offering a range of services for patients with chronic kidney failure. These services include hospital-based and home dialysis, integrated care programs, physician services, and comprehensive kidney care solutions.
As DaVita prepares to announce its fiscal Q4 2025 results, analysts are optimistic about the company’s performance. It is expected to report an adjusted EPS of $3.24, a significant increase of 44.6% from the previous year. For fiscal 2025, analysts predict DaVita to achieve an adjusted EPS of $10.70, up 10.5% from the previous fiscal year. Looking ahead to fiscal 2026, adjusted EPS is projected to grow by 20.5% year-over-year to $12.89.
Despite these positive projections, DaVita’s stock has faced challenges in the market. Over the past 52 weeks, the company’s shares have declined by 36.1%, underperforming major indices such as the S&P 500 and the State Street Health Care Select Sector SPDR ETF. Following the release of its Q3 2025 results, DaVita’s stock tumbled by 6.2%. The decline was attributed to higher patient care costs, increased general and administrative expenses, and lower dialysis volumes. Additionally, the company faced setbacks due to the impact of a ransomware attack in April, which disrupted operations and incurred costs of $11.7 million.
Analysts’ consensus view on DaVita stock remains cautious, with a “Hold” rating overall. Among the eight analysts covering the stock, one recommends a “Strong Buy,” six suggest “Hold,” and one indicates a “Moderate Sell.” The average analyst price target for DaVita is $141, indicating a potential upside of 34.8% from the current levels.
In conclusion, while DaVita has shown strong potential for growth in its core business of kidney dialysis services, the company faces challenges in the market due to operational disruptions and rising costs. Investors will be closely watching the company’s upcoming earnings report to gauge its performance and outlook for the future.
